Leaderboard
Insiders and issuers ranked by realized signed return on open-market Form 4 trades. Returns are signed: a sale followed by a rally counts against the seller.
What the metrics mean
Return - the insider's signed return per trade, averaged. A +10% stock move on a buy scores +10%; on a sell, -10%. Because most insider activity is concentrated at rallying stocks, this metric correlates with raw stock performance and doesn't fully isolate timing skill from market drift.
Edge - signed return minus the stock's average forward N-day return over the same period. An insider with +5% edge consistently chose better days to trade than someone who'd picked a random day in the same window. Isolates timing skill from "the stock just went up."
Neither metric is the same as ranking stocks by raw return - that would just surface the best-performing tickers, which you can get from any market screener.
Issuers ranked
2,356
Showing 50 of 2,356
Quality filters
10+ trades
≥3 insiders, 50% price coverage
Window
5y trailing
Trade date filter
| # | Ticker | Issuer | Trades | Insiders | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|---|---|
| 1 | CLVR | Clever Leaves Holdings Inc. | 25 | 7 | 100% | +885.8% | +902.8% | +941.5% | +789.5% |
| 2 | VAXX | Vaxxinity, Inc. | 51 | 3 | 100% | +765.9% | +778.3% | +788.3% | +733.5% |
| 3 | IONM | Assure Holdings Corp. | 29 | 3 | 100% | +2740.2% | +2743.3% | +2756.9% | +2714.3% |
| 4 | TTOO | T2 Biosystems, Inc. | 171 | 11 | 100% | +119.1% | +118.6% | +129.2% | +34.2% |
| 5 | ASST | Asset Entities Inc. | 24 | 8 | 100% | +113.8% | +120.1% | +135.9% | +59.5% |
| 6 | FXLV | F45 Training Holdings Inc. | 32 | 3 | 100% | +86.5% | +87.5% | +90.3% | +80.5% |
| 7 | QDMI | Qdm International Inc. | 12 | 4 | 100% | +79.0% | +79.0% | +79.0% | +79.0% |
| 8 | QBTS | D-Wave Quantum Inc. | 155/162 | 19 | 89% | +78.1% | +105.4% | +119.1% | -42.9% |
| 9 | NTHI | Neonc Technologies Holdings, Inc. | 21 | 5 | 100% | +77.3% | +79.2% | +79.2% | +40.4% |
| 10 | GTII | Global Tech Industries Group, Inc. | 78 | 4 | 100% | +74.7% | +74.8% | +120.3% | +4.9% |
| 11 | BBGI | Beasley Broadcast Group Inc | 10 | 4 | 100% | +73.7% | +73.7% | +73.7% | +73.7% |
| 12 | MAZE | Maze Therapeutics, Inc. | 31/51 | 6 | 97% | +71.8% | +70.0% | +83.1% | -30.7% |
| 13 | QUBT | Quantum Computing Inc. | 29/31 | 9 | 97% | +71.6% | +77.8% | +105.0% | -43.2% |
| 14 | VOR | Vor Biopharma Inc. | 221/281 | 8 | 100% | +68.9% | +66.3% | +102.2% | +49.6% |
| 15 | PEPG | Pepgen Inc. | 30/31 | 8 | 100% | +64.7% | +65.5% | +93.4% | +18.8% |
| 16 | PXMD | Paxmedica, Inc. | 50 | 5 | 92% | +63.2% | +50.9% | +110.5% | -26.4% |
| 17 | IMRX | Immuneering Corp | 52 | 4 | 100% | +61.9% | +68.7% | +68.7% | +22.8% |
| 18 | CTNT | Cheetah Net Supply Chain Service Inc. | 11 | 6 | 100% | +61.0% | +60.5% | +77.6% | +44.1% |
| 19 | PSIX | Power Solutions International, Inc. | 368 | 8 | 93% | +57.2% | +65.3% | +81.1% | -164.9% |
| 20 | SKYE | Skye Bioscience, Inc. | 100 | 13 | 100% | +55.3% | +50.1% | +69.0% | +37.7% |
| 21 | MIRA | Mira Pharmaceuticals, Inc. | 48 | 3 | 100% | +55.2% | +70.5% | +75.9% | +1.5% |
| 22 | LIDR | Aeye, Inc. | 39 | 8 | 100% | +54.2% | +61.5% | +77.7% | +3.4% |
| 23 | KOD | Kodiak Sciences Inc. | 18/22 | 3 | 83% | +53.6% | +74.5% | +112.1% | -140.1% |
| 24 | RCAT | Red Cat Holdings, Inc. | 35 | 7 | 94% | +52.6% | +57.8% | +79.3% | -20.9% |
| 25 | WLTH | Wealthfront Corp | 15 | 12 | 100% | +52.6% | +52.6% | +52.6% | +52.6% |
| 26 | NNE | Nano Nuclear Energy Inc. | 54 | 8 | 100% | +52.0% | +53.3% | +54.0% | +13.2% |
| 27 | NMRA | Neumora Therapeutics, Inc. | 21 | 6 | 100% | +50.9% | +55.8% | +92.8% | +13.1% |
| 28 | SPRB | Spruce Biosciences, Inc. | 11 | 3 | 100% | +50.2% | +58.9% | +58.9% | +34.7% |
| 29 | CRWV | Coreweave, Inc. | 6,138/8,784 | 14 | 96% | +50.1% | +58.0% | +69.5% | -273.8% |
| 30 | SLNH | Soluna Holdings, Inc | 68/70 | 9 | 96% | +50.1% | +54.5% | +74.0% | -11.9% |
| 31 | LYRA | Lyra Therapeutics, Inc. | 52 | 6 | 100% | +49.3% | +50.3% | +72.6% | +2.0% |
| 32 | UMAC | Unusual MacHines, Inc. | 17/26 | 7 | 76% | +49.2% | +48.9% | +136.0% | -34.0% |
| 33 | ARX | Accelerant Holdings | 12/13 | 4 | 100% | +48.3% | +48.3% | +48.3% | +48.3% |
| 34 | IBIO | Ibio, Inc. | 17 | 3 | 100% | +48.1% | +46.5% | +74.5% | +5.2% |
| 35 | KZR | Kezar Life Sciences, Inc. | 21 | 4 | 90% | +47.4% | +60.8% | +63.2% | -38.2% |
| 36 | EONR | Eon Resources Inc. | 15 | 5 | 100% | +47.3% | +48.2% | +60.0% | +33.8% |
| 37 | GALT | Galectin Therapeutics Inc | 90/91 | 7 | 97% | +47.0% | +53.3% | +64.6% | -76.5% |
| 38 | FULC | Fulcrum Therapeutics, Inc. | 30 | 7 | 93% | +46.4% | +53.2% | +96.0% | -14.0% |
| 39 | EYPT | Eyepoint Pharmaceuticals, Inc. | 121/122 | 15 | 90% | +46.4% | +58.1% | +69.2% | -81.9% |
| 40 | MGNX | MacRogenics Inc | 19 | 6 | 89% | +45.9% | +79.4% | +82.7% | -55.5% |
| 41 | CERO | Cero Therapeutics Holdings, Inc. | 29 | 5 | 100% | +45.5% | +49.4% | +53.5% | +4.2% |
| 42 | GCT | Gigacloud Technology Inc | 944/1,025 | 21 | 98% | +43.5% | +47.3% | +68.4% | -20.2% |
| 43 | MYSZ | My Size, Inc. | 14 | 5 | 100% | +42.0% | +45.1% | +48.2% | +18.4% |
| 44 | APHP | American Picture House Corp | 22/23 | 3 | 100% | +41.6% | +44.2% | +74.7% | +12.4% |
| 45 | AEYE | Audioeye Inc | 17 | 4 | 100% | +40.4% | +40.5% | +59.3% | +12.7% |
| 46 | KRRO | Korro Bio, Inc. | 140/143 | 10 | 81% | +39.2% | +59.2% | +77.7% | -46.2% |
| 47 | SONX | Sonendo, Inc. | 60 | 9 | 90% | +39.2% | +42.5% | +99.4% | -184.9% |
| 48 | WGS | Genedx Holdings Corp. | 268/357 | 22 | 83% | +38.9% | +58.9% | +125.1% | -386.9% |
| 49 | STKS | One Group Hospitality, Inc. | 29 | 5 | 100% | +38.1% | +39.4% | +40.2% | +8.0% |
| 50 | TNGX | Tango Therapeutics, Inc. | 134/139 | 14 | 78% | +37.9% | +52.1% | +97.5% | -56.3% |
Showing 1-50 of 2,356